|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-5.15/-3.86
|
企业价值
3.32B
|
资产负债 |
每股账面净值
7.66
|
现金流量 |
现金流量率
--
|
损益表 |
收益
5.45M
|
每股收益
--
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/18 19:03 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several otherprograms addressing highly prevalent, genetically defined cancers. |